Addition of salmeterol to low-dose fluticasone versus higher-dose fluticasone: An analysis of asthma exacerbations

Journal of Allergy and Clinical Immunology

Volumn 107, Issue 5 SUPPL., 2001, Pages 783-789

  Matz, Jonathan ^a   Emmett, Amanda ^b   Rickard, Kathleen ^b   Kalberg, Christopher ^b  

^a Atlantic Asthma Allerg Ctr   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Asthma exacerbations; Fluticasone propionate; Inhaled corticosteroid; Long acting 2 agonist; Salmeterol xinafoate

Indexed keywords

FLUTICASONE PROPIONATE; SALMETEROL XINAFOATE;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG DELIVERY SYSTEM; DRUG MEGADOSE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035013066     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.114709     Document Type: Article

References (19)

1. National Institutes of Health (National Heart, Lung, and Blood Institute). Expert Panel Report 2. Guidelines for The Diagnosis and Management of Asthma. Bethesda (MD): National Institutes of Health. NIH Publication No. 97-4051; 1997.
2. Bleeker E. Inhaled corticosteroids: Current products and their role in patient care. J Allergy Clin Immunol 1998;101:S400-2.
3. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994;344:219-24.
4. Woolcock A, Lundback B, Ringdal N, Jacques L. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996;153:1481-8.
5. Kelsen SG, Church NL, Gillman SA, Lanier BQ, Emmett AH, Rickard KA, et al. Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: A randomized clinical trial. J Asthma 1999;36:703-15.
6. Murray JJ, Church NL, Anderson WH, Bernstein DI, Wenzel SE, Emmett A, et al. Concurrent use of salmeterol with inhaled corticosteroids is more effective than inhaled corticosteroid dose increases. Allergy Asthma Proc 1999;20:173-80.
7. Condemi JJ, Goldstein S, Kalberg C, Yancey S, Emmett A, Rickard K. The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma. Ann Allergy Asthma Immunol 1999;82:383-9.
8. Kalberg CJ, Nelson H, Yancey S, Petrocella V, Emmett AH, Rickard KA, et al. A comparison of added salmeterol versus increased-dose fluticasone in patients symptomatic on low-dose fluticasone [abstract]. J Allergy Clin Immunol 1998;101(Suppl):S6.
9. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987;136:225-44.
10. Shapiro G, Lumry W, Wolfe J, Given J, White MV, Woodring A, et al. Combined salmeterol 50μg and fluticasone propionate 250μg in the Diskus device for the treatment of asthma. Am J Respir Crit Care Med 2000;161:527-34.
11. Kavuru M, Melamed J, Gross G, LaForCe C, House K, Prillaman B, et al. Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2000;105:1108-16.
12. Aubier M, Pieters WR, Schlosser NJ, Steinmetz KO. Salmeterol/fluticasone propionate (50/500 micrograms) in combination in the Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma. Respir Med 1999;93:876-84.
13. Kemp JP, Cook DA, Incaudo GA, Corren J, Kalberg C, Emmett A, et al. Salmeterol improves quality of life in patients with asthma requiring inhaled corticosteroids. J Allergy Clin Immunol 1998;101:188-95.
14. Lanes SF, Lanza LL, Wentworth CE. Risk of emergency care, hospitalization and ICU stays for acute asthma among recipients of salmeterol. Am J Respir Crit Care Med 1998;158:857-61.
15. Pauwels RA, Lofdahl C-G, Postma DA, Tattersfield AE, O'Byrne P, Barnes PJ, et al. Effect of inhaled formoterol and budesonide on exacerbations of asthma. N Engl J Med 1997;337:1405-11.
16. Tattersfield AE, Postma DS, Barnes PJ, Svensson K, Bauer C, O'Byrne PM, et al. Exacerbations of asthma: A descriptive study of 425 severe exacerbations. Am J Respir Crit Care Med 1999;160:594-9.
17. 2 agonist, assessed in airway biopsies and bronchoalveolar lavage in asthma. Am J Respir Crit Care Med 1999;160:1493-9.
18. Sue-Chu M, Wallin A, WilSon S, Ward J, Sandstrom T, Djukanovic R, et al. Bronchial biopsy study in asthmatics treated with low and high dose fluticasone propionate (FP) compared to low dose FP combined with salmeterol [abstract]. Eur Respir J 1999;14:124S.
19. Kips JC, O'Connor BJ, Inman MD, Svensson K, Pauwels RA, O'Byrne P. A long-term study of the anti-inflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Am J Respir Crit Care Med 2000;161:996-1001.